Treatment of knee pain with combined instrument-assisted soft tissue mobilization

Treatment of patellofemoral joint pain with combined instrument-assisted soft tissue mobilization

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN88098928

Enrollment

Registered

2023-02-07

Start date

2022-09-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral joint pain Musculoskeletal Diseases

Interventions

Patients with patellofemoral joint pain were randomly divided into an instrument-assisted soft tissue mobilization (IASTM) test group and a control group. The IASTM test group was treated with IASTM c

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 35 years old 2. Be able to cooperate with rehabilitation physiotherapy, training and follow-up, and will not withdraw from the study without reason

Exclusion criteria

Exclusion criteria: 1. Exogenous injury of knee joint, including bruise, hit, cut, scald, contusion, etc., without external or subcutaneous bleeding due to skin rupture 2. Abnormal natural bone structure 3. Inflammation, patellar dislocation or subluxation, knee ligament injury 4. History of arthroscopic surgery of knee joint within one year 5. Injury or discomfort of other body parts

Design outcomes

Primary

Measure	Time frame
1. Pain measured using the visual analogue pain score (VAS) assessed before the start of the experiment, and in the first and last weeks of the experiment 2. Knee-specific symptoms measured using the Lysholm Knee Scoring System assessed before the start of the experiment, and in the first and last weeks of the experiment 3. Flexibility of the iliopsoas, rectus femoris and tensor fascia latae (hip flexion contracture and hip extensibility) measured using the modified Thomas test (MTT) assessed before the start of the experiment, and in the first and last weeks of the experiment 4. Muscle strength test measured using the maximum isometric muscle strength test system of the lower limb extensor assessed before the start of the experiment and in the last week of the experiment	—

Measure

Time frame

1. Pain measured using the visual analogue pain score (VAS) assessed before the start of the experiment, and in the first and last weeks of the experiment 2. Knee-specific symptoms measured using the Lysholm Knee Scoring System assessed before the start of the experiment, and in the first and last weeks of the experiment 3. Flexibility of the iliopsoas, rectus femoris and tensor fascia latae (hip flexion contracture and hip extensibility) measured using the modified Thomas test (MTT) assessed before the start of the experiment, and in the first and last weeks of the experiment 4. Muscle strength test measured using the maximum isometric muscle strength test system of the lower limb extensor assessed before the start of the experiment and in the last week of the experiment

—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

China

Contacts

Public ContactYang Liu

784389072@qq.com+8618935836605

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 8, 2026